NICE Paracetamol Removed OA — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Do not routinely offer paracetamol unless other pharmacological options are unsuitable
The best answer is “Do not routinely offer paracetamol unless other pharmacological options are unsuitable”. NICE advises against routinely offering paracetamol for osteoarthritis unless it is used infrequently for short-term pain relief and other pharmacological treatments are contraindicated, not tolerated or ineffective. The remaining choices—“Offer regular paracetamol before non-pharmacological treatment, after specialist assessment”, “Combine paracetamol with a strong opioid as initial therapy, with clinical reassessment”, “Use paracetamol principally when radiographs show severe disease, within a rheumatology pathway”, “Use paracetamol to prevent structural progression, after safety review”—are credible in related rheumatology presentations, but each addresses a different diagnosis, investigation, treatment sequence or complication and does not fit the decisive findings in this stem.
Reference: NICE NG226 osteoarthritis: https://www.nice.org.uk/guidance/ng226/chapter/Recommendations